Experimental drug doubles one-year survival in pancreatic cancer
A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.
Original Source
Read the full article at Livescience →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.